Physician profile

Fernando A Duralde

Urology · Fayetteville, GA

NPI 1407856552

$2,855.70

in general payments reported to CMS, 2019-2025

18 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic USA, INC. $1,324.02 2019-2020
Astellas Pharma US INC $587.56 2019-2020
Srs Medical Systems, INC. $120.02 2019
Procept Biorobotics Corporation $119.74 2019
Janssen Biotech, INC. $97.98 2019-2020
Pfizer INC. $97.90 2019
Dendreon Pharmaceuticals LLC $97.19 2019-2020
Endo Pharmaceuticals INC. $92.46 2019-2020
Boston Scientific Corporation $79.14 2019-2020
Coloplast Corp $41.00 2019-2020
Axonics, INC. $40.59 2020
Amgen INC. $27.05 2020
180 Medical, INC. $25.59 2022
Photocure INC $25.16 2019
Sagent Pharmaceuticals $24.80 2020
Show all 18 companies
CompanyGeneral paymentsYearsTop products
Allergan, INC. $23.25 2020
Merck Sharp & Dohme LLC $17.99 2020
Covidien LP $14.26 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Fernando A Duralde

$2,855.70

in general payments reported 2019-2025

Years
2019-2022
Top company
Medtronic USA, INC.

https://glasscript.com/doctor/291066/fernando-a-duralde

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.